Apr 16, 2024, 01:02
CAR T cells can gain new vigor when engineered to have high levels of a particular protein – Cancer Research Institute
Cancer Research Institute posted on LinkedIn:
“Bioengineered immune cells have been shown to attack and even cure cancer, but often become exhausted over time. Researchers including former CRI Fellow Dr. Junyun Lai of Peter MacCallum Cancer Centre have now demonstrated that CAR T cells can gain new vigor when engineered to have high levels of a particular protein. These boosted CAR T cells have gene activity similar to that of stem cells, and a rejuvenated ability to fend off cancer.
Learn more.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 05:54
Dec 21, 2024, 05:42
Dec 21, 2024, 04:55
Dec 21, 2024, 03:42
Dec 21, 2024, 03:31